Biosimilars are on the rise and are challenging original brands at lower costs. To measure the impact of biosimilars on originator usage, market research is one method of developing these insights. However market research is not the only source of information, analogues can provide similar and/or additional information.

In the upcoming BHBIA Annual Conference 2018, we will share what information can be provided by using which data source and how an originator company can benefit to develop their strategy.

Date and time: Monday 14th of May 2018 at 16.00 CEST
– Vanessa Regester, Insights Manager – Roche UK
– Teresa Nolasco, Principal in Commercial Effectiveness – IQVIA UK
– Adriënne Hoevers – den Hollander, Senior Research Manager – SKIM